Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artelac
- Development stage
- Unknown
- Lead developer
- Bausch + Lomb
- Administration
- Ophthalmic
01
Overview
**Artelac** is a Bausch + Lomb ophthalmic-lubricant brand family used for symptomatic management of **dry eye disease**. The exact formulation is market- and product-specific: products sold under the Artelac name include hypromellose eye drops and lipid-containing lubricating gels or drops containing carbomer and medium-chain triglycerides; other Artelac variants contain additional tear-film-supporting ingredients. These products act locally as artificial tears, improving ocular-surface lubrication, retaining moisture, and, in lipid-containing formulations, supporting the tear-film lipid layer to reduce evaporation.
- Brand names
- Artelac
- Other names
- ocular lubricant
Beyond the preview
Go deeper on Artelac.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Artelac.